SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Kadmon Holdings (KDMN)

KDMN RSS Feed 		Add KDMN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/21/2017 5:15:16 PM - Followers: 5 - Board type: Free - Posts Today: 0

Healthcare-Biotech company developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
KDMN
Current Price
Volume:
Bid Ask Day's Range
KDMN Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
KDMN News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/15/2017 04:06:47 PM
KDMN News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/15/2017 04:06:47 PM
KDMN News: Current Report Filing (8-k) 08/14/2017 05:01:49 PM
KDMN News: Notice of Effectiveness (effect) 08/14/2017 06:01:57 AM
KDMN News: Kadmon to Present Preclinical Data on ROCK Inhibition in Pulmonary Fibrosis at IPF Summit 2017 08/11/2017 09:00:00 AM
News News Alert: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 08/15/2017 04:06:47 PM
PostSubject
#7   KDMN buy 3.56 stocktrademan 06/21/17 05:15:16 PM
#6   Watching T695 04/06/17 09:27:38 PM
#5   Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM
#4   Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM
#3   Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM
#2   KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM
#1   Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM
PostSubject
© 2017 InvestorsHub.Com, Inc.